News dated May
http://www.reuters.com/article/pressRele...

they are expecting approval for these kind of devices, easier to use and cheaper. Once they get approval for the device, their diagnostic kits are going to get dramatically increased (probably second half 2009). Althought they are already experiencing explosive growth in this segment
they are expecting approval for 3 more diagnostic kits:

AIDS Early Examination Kit
Carcinoma Cervix Early Examination Kit
Breast Cancer Early Examination Kit

My recommendation, keep your shares at least for a couple of years, don´t be tempted to sell at 25 or 30 $, in 2-3 years this company will play a significant role in China´s biotechnology market. You might miss the big run